DarlenePatriciaHortonMD

Pediatric Cardiology • San Francisco, CA

Pediatric Cardiac Genetics

Physician

Join to view full profile

Dr. Horton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Horton's full profile

Already have an account?

Office
850 De Haro St
San Francisco, CA 94107
Phone+1 415-285-6075

Fax+1 415-285-6085

Education & Training

University of California (San Francisco)Fellowship, Pediatric Cardiology, 1993 - 1996
University of California (San Francisco) School of MedicineInternship, Transitional Year, 1988 - 1989
University of Florida College of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1989 - 2025

Publications & Presentations

PubMed

1500 citations
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 ca...
Kirkwood F. Adams, Gregg C. Fonarow, Charles L. Emerman, Thierry H. LeJemtel, Maria Rosa Costanzo
American Heart Journal. 2005-02-01
162 citations
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Marc A. Silver, Darlene P. Horton, Jalal K. Ghali, Uri Elkayam
Journal of the American College of Cardiology. 2002-03-06
11 citations
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomy...
Andrew J. Burger, Doron Aronson, Darlene P. Horton, Mary R. Burger
The American Journal of Cardiology. 2003-06-01

Press Mentions

Recursion CSO Heads West for Mini-Brain Upstart; Novartis Vet Steps up to the Plate as CFO for Andrew Hirsch at C4 TherapeuticsMay 28th, 2021
Napo Pharmaceuticals, Jaguar Health’s Subsidiary, Bolsters Management Team with Appointment of Darlene Horton, M.D. As Chief Medical OfficerMay 26th, 2021
Coherus BioSciences Appoints Darlene Horton, M.D., Chief Medical and Regulatory Affairs OfficerJanuary 2nd, 2019